Schnellzugriff
- Direkt zur Sitemap
- Direkt zur Suche
- Direkt zur Startseite
- Direkt zu Zugang für Alle
- Direkt zur Navigation
- Direkt zum Inhalt
- Direkt zum Kontakt
The Swiss stock market heavyweights Nestlé, Novartis and Roche together account for half of the weightings of the Swiss Market Index. The relative stability of these stocks makes them popular underlyings for defensive yield enhancement products.
In combination with other stocks from the leading index, attractive returns can be generated despite the tendency towards low volatility.
| Type | Valor | Underlyings | Coupon p.a. | Barrier | Duration (m) | Currency | Subsciption until |
| RC | 127347056 | Nestlé, Novartis, Roche | 7% | 90% Strike | 12 | CHF | 27.10.2023 |
| CBRC | 127347026 | Nestlé, Novartis, Roche | 5% | 61% | 18 | CHF | 01.11.2023 |
| CBRC | 127347028 | Nestlé, Novartis, Roche, UBS, Zurich | 8% | 59% | 12 | CHF | 01.11.2023 |
| Other Products with SMI® Underlyings | |||||||
| CBRC | 127347041 | UBS, Lonza, Richemont, Sika, Logitech | 10% | 50% | 12 | CHF | 27.10.2023 |
| BRC | 127347042 | Julius Bär, Swatch, Givaudan | 8% | 60% | 12 | CHF | 27.10.2023 |
| BRC | 127347043 | Alcon, Swisscom, Holcim | 8% | 65% | 12 | CHF | 27.10.2023 |
| BRC | 127347044 | Alcon, Straumann, Sonova | 8% | 63% | 12 | CHF | 27.10.2023 |
| CBRC | 127347048 | Geberit, Givaudan, ABB | 7% | 65% | 12 | CHF | 27.10.2023 |
| CBRC | 127347051 | Lonza, Julius Bär, Swiss Life | 10% | 63% | 12 | CHF | 27.10.2023 |
| BRC | 127347052 | Zurich, Swiss Life, Swiss Re | 7% | 65% | 12 | CHF | 27.10.2023 |
| BRC | 127347053 | SGS, Kühne + Nagel, Adecco | 8% | 62% | 12 | CHF | 27.10.2023 |
| BRC | 127347054 | Logitech | 8% | 70% | 12 | CHF | 27.10.2023 |
| BRC | 127347055 | Julius Bär | 7% | 70% | 12 | CHF | 27.10.2023 |
| BRC | 127347060 | UBS, Julius Bär, Vontobel | 9% | 59% | 18 | CHF | 27.10.2023 |
| RC | 127347057 | Richemont | 8% | 0% | 6 | CHF | 27.10.2023 |
| BRC | 127347027 | Zurich, Swiss Life, Swiss Re | 6% | 59% | 18 | CHF | 01.11.2023 |
Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements.
The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document.
If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.
